Rapid COVID-19 Test Available Now 

54 Samples | 54o Tests | 4 Hours

Randox has developed a rapid test for COVID-19 (SARS-CoV-2), the new strain of coronavirus.

The only test in the world that can identify the lethal strain and differentiate between other non-lethal variants with the same symptoms.

The new test utilises Randox Biochip Technology, reporting 540 results in less than 5 hours on the Randox Evidence Investigator, a semi-automated analyser that is capable of processing 54 patient samples simultaneously.

Extended Coronavirus Array


Five strains of coronavirus including SARS-CoV-2 (SARS-CoV-2, 229E, NL63, OC43 and HKUI) are detected on this panel. The wider panel provides a more comprehensive respiratory screen enabling informed treatment decisions to be made.


SARS-CoV-2 (COVID-19)Adenovirus A/B/C/D/E
(SARS, SARS like, SARS-CoV-2)
Enterovirus A/B/C
Coronavirus 229E/NL63Influenza A
Coronavirus OC43/HKUIInfluenza B
Middle East Respiratory
Syndrome Coronavirus (MERS-CoV)
Rhinovirus A/B

Randox | Investigator


The Evidence Investigator is a compact semi-automated benchtop analyser. It is a perfect fit for medium throughput laboratories seeking maximum use of bench space without compromising on the volume of samples processed.

  • Estimated turnaround time of less than 5 hours
  • Medium to high throughput (Capable of processing 54 samples and reporting 540 results in less than 5 hours)
  • Detection from nucleic acid
  • Batch testing
  • Suitable for laboratory setting
  • Comprehensive test menu